Approved Research This page provides a searchable list of all research protocols that have been reviewed and approved by the Uganda National Council for Science and Technology(UNCST).
Search By Approval Date:
Clear Filter Total: 6,466
Name Title Nationality Approval Date Expiry Date Field of Science/Classification Trial Type Research Type  
ucama Patrick ufoymungu
ID: UNCST-2023-R006573
PERFORMANCE OF APRI SCORE COMPARED TO FIBROSCAN IN THE ASSESSMENT OF FIBROSIS AMONG ADULTS WITH CHRONIC HEPATITIS B INFECTION AT MBARARA REGIONAL REFERRAL HOSPITAL
REFNo: HS4174ES

3. To determine the degree of agreement or disagreement between FibroScan and APRI Score in assessing the presence or absence of liver fibrosis among adults with Chronic Hepatitis B infection at the hepatitis clinic of Mbarara Regional Referral Hospital.,2. To identify the factors associated with liver fibrosis among adults with Chronic Hepatitis B infection at the hepatitis clinic of Mbarara Regional Referral Hospital.,1. To determine the prevalence of liver fibrosis among adults with chronic hepatitis B infection by using FibroScan and APRI Score at the hepatitis clinic of Mbarara Regional Referral Hospital.,To compare the performance of APRI score to Fibroscan in the assessment of fibrosis among adults with chronic hepatitis B infection at Mbarara Regional Referral Hospital.,
Burundi 2024-06-12 14:22:59 2027-06-12 Medical and Health Sciences Non-Clinical Trial Degree Award
Orla Walsh
ID:
Staff Experiences of PAIRS Training
REFNo: HS4309ES

To determine the availability and adequacy of resuscitation equipment and supplies in the selected health centres. ,To explore the experiences of staff who have received PAIRS training and compare responses of staff within these centres who have not participated in PAIRS. ,
Ireland 2024-06-12 14:22:12 2027-06-12 Medical and Health Sciences Non-Clinical Trial Non-degree Award
Maria Kasirye Ella
ID:
INFLUENCE OF SIGNIFICANT DEPRESSION SYMPTOMS ON ADHERENCE TO TENOFOVIR BASED ANTIRETROVIRAL THERAPY AT 24 MONTHS AMONG 18 TO 35-YEAR-OLD WOMEN LIVING WITH HIV IN KAMPALA; A LONGITUDINAL STUDY
REFNo: HS4301ES

3. To determine the association between the longitudinal patterns of significant depression symptoms and adherence to ART in 18 to 35-year-old women living with HIV on Tenofovir-based regimens in Kampala district.,2. To assess the longitudinal patterns of significant depression symptoms in 18 to 35-year-old women living with HIV on Tenofovir-based regimens in Kampala district.,1. To determine the baseline prevalence of significant depression symptoms in 18 to 35-year-old women living with HIV on Tenofovir-based regimens in Kampala district.,• To determine the longitudinal patterns of significant depression symptoms and their influence on antiretroviral therapy adherence among 18 to 35-year-old women living with HIV on Tenofovir-based regimens in Kampala, Uganda.,
Uganda 2024-06-12 14:21:19 2027-06-12 Medical and Health Sciences Non-Clinical Trial Degree Award
Job Kalema
ID: UNCST-2021-R013087
PEER ASSESSMENT FRAMEWORK TO SUPPORT GROUP-BASED ASSESSMENT IN E-LEARNING ENVIRONMENT FOR HIGHER INSTITUTIONS OF LEARNING
REFNo: SIR341ES

To evaluate the designed peer assessment framework using the DeLone and McLean model.,To design a peer assessment framework for group-based assessment based on the requirements gathered in (i) above.,To gather the requirements of group-based assessment frameworks used in universities.,The purpose of this study is to build the peer assessment framework for group-based assessment that improves interactions in the online learning environment for Universities.,
Uganda 2024-06-12 14:20:29 2027-06-12 Engineering and Technology Non-Clinical Trial Degree Award
Nathan Kenya-Mugisha
ID: UNCST-2021-R013752
Validation of a cross-outbreak stigma scale in infectious disease outbreak-affected communities (2022 Ugandan Ebola outbreak component )
REFNo: SS2727ES

: Understand how stigma impacts outbreak control (and vice versa), and how this stigma could be validly and effectively assessed.,Use the stigma scale in three different outbreak contexts (specifically communities affected by Ebola in Uganda for purposes of this application) to measure disease-related stigma.,Co-develop and validate a cross-outbreak stigma scale,To administer and validate a stigma scale to assist with recognition and reduction of infectious disease outbreak-related stigma in affected communities (specifically communities affected by Ebola in Uganda).,
Uganda 2024-06-12 14:16:19 2027-06-12 Social Science and Humanities Non-Clinical Trial Degree Award
View Sort By:

"A prosperous Science and Technology Led Ugandan Society."